Insider Selling: Xenon Pharmaceuticals Inc. (NASDAQ:XENE) CEO Sells 31,655 Shares of Stock

Xenon Pharmaceuticals Inc. (NASDAQ:XENE – Get Rating) CEO Ian Mortimer sold 31,655 shares of the stock in a transaction on Wednesday, May 24th. The shares were sold at an average price of $41.41, for a total transaction of $1,310,833.55. Following the completion of the transaction, the chief executive officer now owns 24,213 shares of the […]

Related Keywords

Canada ,Simon Neil Pimstone ,Ian Mortimer ,Xenon Pharmaceuticals Price Performance ,Xenon Pharmaceuticals Company Profile ,Royal Bank ,Marshall Wace ,Quarter For Xenon Pharmaceuticals ,Institutional Trading Of Xenon Pharmaceuticals ,Nasdaq ,Xenon Pharmaceuticals Inc ,Jpmorgan Chase Co ,Xenon Pharmaceuticals ,Cantor Fitzgerald ,Needham Company ,News Ratings For Xenon Pharmaceuticals Daily ,Goldman Sachs Group Inc ,Get Rating ,Goldman Sachs Group ,Sachs Group ,Xenon Pharmaceuticals Daily ,Nasdaq Xene ,Exene ,Medical ,Insider Trading ,Nsider Trades ,Stocks ,